Hypercalcemia and antithrombin activity in a case of IgA myeloma
Baele, G.; Lameire, N.
Nederlands Tijdschrift Voor Geneeskunde 116(33): 1444-1450
1972
ISSN/ISBN: 0028-2162 PMID: 5069831 Document Number: 45622
Document emailed within 1 workday
Related Documents
Abe, M. 2007: Hypercalcemia in myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 65(12): 2245-2249Goldsmith, R.E. 1973: Hypercalcemia and myeloma Annals of Internal Medicine 79(2): 289
Schoevaerdts, D.; Mineur, P.; Hennaux, V.; Sibille, C. 1999: Hypercalcemia, chronic lymphocytic leukemia and multiple myeloma: uncommon association Acta Clinica Belgica 54(4): 217-219
Belitser, V.A.; Musialkovskaia, A.A.; Platonova, T.N.; Ena, I.M. 1987: Determination of the antithrombin IIi activity of the blood Laboratornoe Delo 4: 255-259
Ferrari, S.; Brazzoli, C.; Pezzini, M.B.; Zanoio, L.; Benini, F. 1981: Antithrombin activity during estroprogestin therapy Minerva Ginecologica 33(5): 429-432
Huang, C.S.; Lee, K.Y. 1985: Antithrombin III activity in stroke patients Journal of the Formosan Medical Association 84(1): 53-58
Nakagawa, M.; Okada, T.; Okuda, S.; Nishizawa, A.; Watada, M. 1977: Exogenous heparin and antithrombin activity Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 40(2): 207-212
De la Piedra, C.; Rapado, A.; Esbrit, P. 1985: Serum levels of osteocalcin in hypercalcemia caused by primary hyperparathyroidism and in tumor hypercalcemia Revista Clinica Espanola 177(7): 310-313
Gerhards, H. 1987: Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency Tierarztliche Praxis 15(1): 47-55
Jeong, H.; Kim, M.; Lee, J.; Hahn, S.H.; Park, S.; Yoo, O.J. 1997: A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency Thrombosis and Haemostasis 77(1): 212-213
Weiler, J.M.; Linhardt, R.J. 1991: Antithrombin III regulates complement activity in vitro Journal of Immunology 146(11): 3889-3894
Mach, U.; Puzyna, W. 1987: Effect of heparin treatment on antithrombin IIi (AT III) activity Ginekologia Polska 58(8): 544-547
Weiner, C.P.; Kwaan, H.C.; Xu, C.; Paul, M.; Burmeister, L.; Hauck, W. 1985: Antithrombin IIi activity in women with hypertension during pregnancy Obstetrics and Gynecology 65(3): 301-306
Fujimaki, M.; Nagasawa, H. 1974: Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3 Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 942-947
Maak, B.; Kauf, E.; Spahn, U.; Hobert, I. 1987: Behavior of antithrombin IIi activity in children with diabetes mellitus Kinderarztliche Praxis 55(10): 499-504
Zuck, T.F.; Bergin, J.J.; Raymond, J.M.; Dwyre, W.R. 1971: Implications of depressed antithrombin-3 activity associated with oral contraceptives Surgery Gynecology and Obstetrics 133(4): 609-612
Nagy, I.; Losonczy, H. 1982: Comparative studies on the determination of abnormal antithrombin IIi activity Folia Haematologica 109(1): 180-183
Stephens, K.A.; Morcom, E.; Hood, D.M. 1984: Measurement of plasma antithrombin III activity in healthy horses American Journal of Veterinary Research 45(2): 351-353
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
Belitskaia, G.A.; Ena, L.M. 1974: Correlation between the antithrombin activity of urine and blood in patients with glomerulonephritis Vrachebnoe Delo 11: 103-107